Previous Article | Next Article 
Infection and Immunity, October 1999, p. 5409-5416, Vol. 67, No. 10
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Redox Imbalance Differentially Inhibits
Lipopolysaccharide-Induced Macrophage Activation in the Mouse
Liver
Fuan
Wang,
Luke Y.
Wang,
Douglas
Wright, and
Michael J.
Parmely*
Department of Microbiology, Molecular
Genetics and Immunology, University of Kansas Medical Center,
Kansas City, Kansas 66160-7420
Received 1 April 1999/Returned for modification 22 June
1999/Accepted 23 July 1999
 |
ABSTRACT |
Endotoxemia is accompanied by significant changes in the
reductive-oxidative (redox) balance of critical target organs. Redox stress has been shown to regulate the expression of proinflammatory genes that are induced by endotoxic lipopolysaccharide (LPS) in vitro;
however, much less is known about the effects of redox imbalance on
LPS-induced gene expression in vivo. To assess the effects of redox
stress on inflammatory responses in endotoxemia, mice were treated with
either diethyl maleate (DEM), a glutathione-depleting agent, or
buthionine sulfoximine (BSO), an inhibitor of glutathione synthesis,
and challenged with LPS. While serum tumor necrosis alpha (TNF-
)
responses and the appearance of TNF-
-positive Kupffer cells in the
liver were virtually eliminated by DEM or BSO treatment, the expression
of both CD14 and inducible NO synthase (iNOS) by Kupffer cells was
unaffected by glutathione depletion. By contrast, LPS-induced
hepatocyte and hepatic sinusoidal endothelial cell iNOS expression was
significantly inhibited in DEM-treated mice. Hepatocyte iNOS induced by
recombinant mouse TNF-
was also inhibited by DEM treatment. These
results indicate that the effects of oxidative stress in this organ are
cell type specific and suggest that both the production and the action
of TNF-
are substantially influenced by the redox state of the liver
during endotoxemia.
 |
INTRODUCTION |
Sepsis is a complex biological
response to infection that involves the action of a number of
proinflammatory cells and soluble mediators. One of the hallmarks of
this condition is the production of reactive oxygen and nitrogen
intermediates that have a range of biological effects, including
antimicrobial activity and the induction of host tissue damage. Several
observations, including the appearance of circulating lipid
peroxidation products, changes in tissue antioxidant levels, and the
expression of stress-responsive genes, suggest that reactive oxygen and
nitrogen intermediates are produced at high concentrations in animals
challenged with endotoxic lipopolysaccharide (LPS) (12, 21, 46,
48, 55, 56, 61). These findings also indicate that significant
changes in the reductive-oxidative (redox) state of tissues occur
during endotoxemia and are due, in part, to the release of radicals and other pro-oxidants from activated inflammatory cells (4, 29, 60).
The expression of many LPS-inducible inflammatory genes can be
regulated by redox stress in vitro (10, 14, 19, 37, 39, 42,
47), and evidence suggests that reduced oxygen intermediates and
nitric oxide-derived metabolites can mediate many of these effects
(14, 19, 47). Thus, altered cellular redox balance can be
viewed as an important means of regulating the expression of
LPS-induced genes, suggesting that reactive oxygen and nitrogen species
may even be integral intermediates in certain LPS signaling pathways
(43).
Glutathione plays a central role in maintaining intracellular redox
balance (11, 58). Reduced glutathione sulfhydryl (GSH) is
the most plentiful nonprotein thiol within cells and serves as a major
antioxidant by ensuring a highly reduced intracellular environment.
Several changes in the glutathione redox cycle, including the depletion
of total cellular glutathione, decreases in the ratio of GSH to
glutathione disulfide, and the inhibition of important glutathione-associated enzymes (e.g., glutathione reductase), can lead
to redox stress. For example, diethyl maleate (DEM) conjugates directly
with GSH and rapidly depletes the antioxidant (11). For this
reason the compound has been widely used to induce redox stress both in
vitro and in vivo. Glutathione can also be depleted by blocking its
biosynthesis with buthionine sulfoximine (BSO), which inhibits the
rate-limiting enzyme
-glutamylcysteine synthase (22).
Treating either animals or cells with DEM or BSO induces the expression
of a variety of stress-responsive genes, including those for the heat
shock protein HSP-32 and metallothionein-1 (15, 20, 49).
The tissue macrophage plays a central role in the systemic inflammatory
response to endotoxin in the mouse, given its wide anatomical
distribution, its sensitivity to activation by LPS, and the ability of
the cell to produce large quantities of key inflammatory mediators,
such as interleukin 1
, tumor necrosis factor alpha (TNF-
), and
nitric oxide. For this reason, a number of investigators have asked to
what extent redox stress can influence macrophage responses to LPS in
vitro. Reactive oxygen and nitrogen species derived from exogenous
chemical sources (e.g., NO donors) as well as exogenous antioxidants,
radical scavengers, NO synthase inhibitors, and agents that deplete
glutathione have been used to alter cellular redox balance in this
context (14, 23, 25, 39, 41, 42, 52). The results of these
in vitro studies have indicated that the LPS-induced expression of many
murine macrophage genes, including that of the TNF-
, inducible NO
synthase (iNOS), and granulocyte-macrophage colony-stimulating factor
genes, is redox regulated (14, 23, 25, 39, 41, 42). However, much less is known about the effects of redox stress on macrophage responses to LPS in vivo or the specificities of these effects in
LPS-challenged animals.
This study was designed to address these important topics. We have
analyzed LPS-induced inflammatory responses in the liver for several
reasons. The liver contains large numbers of tissue macrophages (i.e.,
Kupffer cells), and these cells contribute significantly to the
elevated circulating levels of inflammatory mediators induced by LPS
challenge (7, 27). In addition, several Kupffer cell
responses to LPS are shared by neighboring hepatic parenchymal cells,
affording us the opportunity to compare the effects of redox imbalance
on macrophages to its effects on other hepatic cell types. The findings
reported here indicate the existence of inherently stress-sensitive and
stress-resistant LPS signaling pathways in the liver and suggest that
the redox state of Kupffer cells may have profound effects on
inflammatory responses of other cells in this important shock organ.
 |
MATERIALS AND METHODS |
Reagents.
LPS from Salmonella enteritidis, DEM,
BSO, 5,5'-dithio-bis(2-nitrobenzoic acid), Nonidet P-40, glutathione
reductase, lactate dehydrogenase, hydrogen peroxide, cold-water fish
skin gelatin, and paraformaldehyde were obtained from Sigma Chemical
Co. (St. Louis, Mo.). A single lot of S. enteritidis LPS
(no. 65H4069) was used for the experiments reported here. Paraplast
X-Tra was purchased from Fisher Scientific (St. Louis, Mo.).
Peroxidase-conjugated streptavidin was from BioGenex (San Ramon,
Calif.). Aspergillus nitrate reductase was obtained from
Boehinger Mannheim (Indianapolis, Ind.). Normal goat serum, rabbit
serum, and immunoglobulin G (IgG) and protease-free bovine serum
albumin were purchased from Jackson ImmunoResearch (West Grove, Pa.).
Avidin-biotin blocking and diaminobenzidine chromogen kits were
obtained from Vector Laboratories (Burlingame, Calif.). Recombinant
mouse TNF-
was kindly provided by Genentech (South San Francisco,
Calif.).
Animals.
Female 6- to 10-week-old C3HeB/FeJ and CF1 mice
were purchased from Jackson Laboratories (Bar Harbor, Maine) and
Charles River (Wilmington, Mass.), respectively. Both strains are LPS
responsive (lps+). The animals were maintained
on 12-h light-12-h dark cycles, with food and water being given ad
libitum in an American Association of Laboratory Animal Care-accredited
facility at the University of Kansas Medical Center. Animal care and
use protocols were approved by an institutional animal care and use committee.
Measurement of glutathione.
Mouse tissues were rapidly
frozen in liquid nitrogen, and extracts were prepared by homogenizing
the tissues in 0.125 M phosphate-EDTA buffer with a Polytron tissue
homogenizer (Brinkman Instruments, Westbury, N.Y.). Following
centrifugation, the extracts were deproteinized by the addition of a
6% (vol/vol) solution of 0.1 M HCl and a 6% (vol/vol) solution of
50% sulfosalicylic acid as described by Tietze (57). After
centrifugation at 20,000 × g for 20 min, samples were
neutralized with 3 M K2PO4. The total
glutathione concentrations (reduced plus oxidized) of tissue extracts
were determined by the recycling assay described by Tietze
(57) and were expressed as nanomoles of glutathione per
milligram of protein. Protein concentrations were determined according
to the method of Bradford (5) with a Bio-Rad (Hercules,
Calif.) protein dye reagent.
Assay for TNF-
.
The concentrations of TNF in mouse sera
were determined by the L929 cell cytotoxicity assay as previously
described (44). Serum samples were diluted 1:4 prior to the
assay, which resulted in a detection limit of 40 U/ml. None of the
chemicals used to induce stress affected the killing of L929 cells by
recombinant mouse TNF-
.
Measurement of serum nitrate and nitrite.
The concentrations
of nitrate and nitrite (the principal metabolites of nitric oxide in
blood) were measured in serum samples by a modification of the
procedure described by Schmidt et al. (53). Briefly, the
nitrate in 5- to 10-µl samples of serum was reduced to nitrite by the
addition of 200 mU of nitrate reductase/ml, 100 µM NADPH, and 5 µM
flavine adenine dinucleotide in 20 mM Tris buffer, pH 7.6. After the
reaction mixtures were incubated at 37°C for 45 min, the excess NADPH
was oxidized with lactate dehydrogenase (10 U/ml) in the presence of 10 mM sodium pyruvate. Nitrite was then determined in a two-step procedure
by first adding 2 mM sulfanilamide and by then adding 4% (vol/vol)
concentrated HCl. After 15 min, 0.2 mM naphthylethylenediamine was
added and the incubation was continued for an additional 10 minutes.
Absorbance was read at 550 nm, and nitrite concentrations were
extrapolated from a standard curve prepared with NaNO2.
Immunohistology.
Liver tissue was fixed in freshly prepared
4% paraformaldehyde in 0.1 M phosphate buffer at 4°C for 12 h.
Following overnight washing in cold phosphate-buffered saline, the
fixed tissues were dehydrated in graded ethanol and embedded in
Paraplast X-Tra by standard procedures. Five-micrometer-thick sections
were cut and deposited onto Superfrost slides (Fisher Scientific,
Pittsburgh, Pa.).
The primary antibodies used in this study included the following:
purified rat monoclonal anti-mouse macrophage F4/80 antibody (3), rat monoclonal anti-mouse TNF-
(MP6-XT22) antibody
(Pharmingen, San Diego, Calif.), affinity-purified rabbit anti-mouse
iNOS (M-19) antibody from Santa Cruz Biotechnology, Inc. (Santa Cruz,
Calif.), rat monoclonal anti-mouse CD14 antibody (rmC5-3; Pharmingen), and rabbit anti-HSP-32 antibody (SPA895; StressGen, Victoria, British
Columbia, Canada).
Immunohistochemical staining was performed by the indirect
peroxidase-conjugated streptavidin procedure (18) with the
following modifications. All incubations were performed at room
temperature. Briefly, deparaffinized sections were incubated in a
blocking solution consisting of phosphate-buffered saline containing
0.5% bovine serum albumin, 0.5% gelatin, and either 5% normal goat serum (for the iNOS and HSP-32 antibodies) or 5% normal rabbit serum
(for the TNF-
, CD14, and F4/80 antibodies). The respective blocking
solution was also used as a dilution medium for all primary and
secondary antibodies. Following initial blocking, sections were treated
with an avidin-biotin blocking reagent according to the instructions of
the manufacturer (Vector Laboratories). The sections were then
incubated for 2 h with antibody to either TNF-
, CD14, iNOS, or
F4/80 at concentrations of 10, 10, 1, or 10 µg/ml, respectively.
After the sections were washed, either biotinylated goat anti-rabbit
IgG diluted 1:30 (BioGenex) or biotinylated rabbit anti-rat IgG (Vector
Laboratories) at a concentration of 10 µg/ml was added for 30 min.
After further washing, the sections were treated for 15 min with 1%
H2O2 in methanol to inactivate endogenous
peroxidases. The bound secondary antibodies were then detected by
incubating sections with a peroxidase-streptavidin conjugate diluted
1:30 (BioGenex). Reaction sites were visualized with diaminobenzidine
according to the manufacturer's instructions. Sections were
counterstained with Gill II hematoxylin (Shandon, Pittsburgh, Pa.).
All slides were read independently by two individuals. The densities of
positively stained Kupffer cells and hepatocytes were determined for at
least five microscopic fields (magnification, ×200) and expressed as
cells per high-power field (HPF). Hepatic sinusoidal endothelial cells
were scored in a semiquantitative fashion, with
, +, ++, and +++
representing negative, faint, moderate, and strong staining, respectively.
 |
RESULTS |
DEM depletes glutathione and induces stress responses in the mouse
liver.
Dose-response experiments indicated that an intraperitoneal
(i.p.) injection of DEM at a dose of 5.3 mmol/kg of body weight was
sufficient to decrease levels of glutathione in the livers of C3HeB/FeJ
mice by 90% within 2 h (Fig. 1A).
Glutathione levels remained depressed for at least 6 h thereafter.
To determine whether DEM treatment also led to the expression of
oxidant-stress-responsive genes, immunohistological techniques were
used to detect the heat shock protein HSP-32 in the liver. Kupffer
cells, hepatocytes, and sinusoidal endothelial cells from DEM-treated
mice (Fig. 1B and 2A)
each expressed HSP-32, indicating that glutathione depletion was
associated with stress protein expression in several different hepatic
cell types. Therefore, in subsequent experiments redox stress was
induced by treating mice with DEM at a dose of 5.3 mmol/kg for 2 h
prior to LPS challenge.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 1.
DEM depletes liver glutathione and induces HSP-32
expression in C3HeB/FeJ mice. (A) Four mice in each group were injected
i.p. with the indicated doses of DEM, and their hepatic and splenic
glutathione levels were measured 2 h later. Levels of both hepatic
and splenic glutathione in the group receiving 5.3 mmol of DEM/kg were
significantly different from the levels of the control group
(P < 0.005) as determined by Student's t
test. (B) Mice were injected i.p. with 5.3 mmol of DEM per kg, and
HSP-32 expression in their livers was characterized 5 h later by
immunohistology. Five HPFs (magnification, ×200) were examined for
each section. The two groups in panel B are significantly different
from one another (P < 0.01) as calculated by
Student's t test. Each group contained four mice.
|
|

View larger version (132K):
[in this window]
[in a new window]
|
FIG. 2.
Expression of HSP-32, TNF- , CD14, and iNOS in the
livers of control and DEM-treated C3HeB/FeJ mice. One group of mice was
injected with DEM (5.3 mmol/kg i.p.), and HSP-32 expression was
determined 5 h later. The remaining mice were pretreated with
either DEM or the vehicle for 2 h and were then challenged i.p.
with either 100 µg of S. enteritidis LPS/kg or 12 µg of
recombinant mouse TNF- /kg. With the LPS-challenged mice, liver
samples were recovered 1 h later to measure TNF- expression or
6 h later to measure CD14 and iNOS expression. In mice challenged
with recombinant TNF- , tissues were collected 12 h after
challenge. (A) HSP-32 staining in DEM-treated mice. Note that Kupffer
cells (filled arrow), hepatocytes (open arrow), and sinusoidal
endothelial cells (arrowhead) all expressed HSP-32. (B) TNF- staining in the vehicle
control, LPS-challenged mice. Shown here are TNF- -expressing Kupffer
cells (arrow). (C) TNF- staining in DEM-treated, LPS-challenged
mice. Note the absence of TNF- -positive Kupffer cells. (D) Kupffer
cells (arrow) identified by staining with F4/80 antibody. (E)
Preabsorbing the anti-TNF- antibody with recombinant TNF- blocked
staining in the vehicle control, LPS-challenged mice. (F) CD14 staining
in the vehicle control, LPS-challenged mice. Shown here are
CD14-positive Kupffer cells (arrow) and moderately stained sinusoidal
endothelial cells (arrowhead). (G) CD14 staining in DEM-treated,
LPS-challenged mice. Note that the staining of Kupffer cells (arrow) is
similar to what was seen in the control, LPS-challenged group. (H) iNOS
staining in control, LPS-challenged mice. Note that Kupffer cells
(filled arrow), hepatocytes (open arrow), and sinusoidal endothelial
cells (arrowhead) all express iNOS. (I) iNOS staining in DEM-treated,
LPS-challenged mice. While Kupffer cells remained strongly iNOS
positive (arrow), sinusoidal endothelial cells (arrowhead) were only
faintly stained and there was no hepatocyte iNOS staining. (J)
Preabsorption of the iNOS antibody with the immunizing iNOS peptide
abolished staining in the control, LPS-challenged group. (K) iNOS
staining in control, recombinant-TNF- -challenged mice. Note that
iNOS staining is essentially seen only in hepatocytes (open arrow). (L)
iNOS staining in DEM-treated, recombinant-TNF- -challenged mice
showing the loss of hepatocyte iNOS expression. The original
magnification for panels B to G, K, and L was ×360. For panels I and J
the magnification was ×300, and for panels A and H the magnification
was ×250.
|
|
Redox stress differentially inhibits Kupffer cell gene expression
in mice challenged with endotoxic LPS.
Because it has been
reported that LPS-induced Kupffer cell TNF-
production in vitro is
regulated by intracellular thiol content (39), we first
characterized the effects of DEM on serum TNF-
levels in
LPS-challenged mice. As shown in Fig. 3A,
serum TNF-
responses to challenge with 100 µg of LPS were
completely inhibited by DEM treatment compared to the responses of
control mice that had been pretreated with the drug vehicle (sesame
oil) and then challenged with LPS. This result indicated that TNF-
responses to LPS in vivo were highly sensitive to tissue redox changes, which was confirmed by treating mice with BSO to inhibit glutathione synthesis (Fig. 3B). Under conditions in which BSO inhibited hepatic glutathione levels by 86%, serum TNF-
responses to LPS were reduced to near background levels.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 3.
Treating mice with DEM or BSO inhibits serum TNF-
responses to LPS challenge. (A) C3HeB/FeJ mice
(lps+) were injected with either sesame oil
(vehicle) or DEM i.p. The animals were challenged i.p. 2 h later
with 100 µg of S. enteritidis LPS, and serum samples were
collected 1 h later. (B) CF1 mice (lps+)
were injected with 0.15 M NaCl (vehicle) or 5 mmol of BSO in 0.15 M
NaCl 6 h and again 3 h prior to LPS challenge. Serum samples
were collected 1 h after LPS challenge, and TNF- concentrations
were measured. Each point represents the result with an individual
animal (five to six mice per group), and the horizontal lines represent
group means. In both panels A and B the two groups are significantly
different from one another (P < 0.005), as calculated
by Student's t test.
|
|
To determine whether DEM decreased circulating TNF-
levels by
inhibiting its biosynthesis or enhancing the metabolism of the
cytokine, the frequency of TNF-
-producing Kupffer cells in the liver
was measured by immunohistological techniques. The liver was selected
for this purpose because the organ is a major source of circulating
TNF-
produced in response to LPS (7, 27). Mice that were
either challenged with 100 µg of S. enteritidis LPS or
pretreated with the drug vehicle and then challenged with LPS showed
significant numbers of TNF-
-expressing Kupffer cells in their livers
(Fig. 2B). Pretreating mice with DEM virtually eliminated this response
(Fig. 2C). The TNF-
-positive cells were identified as Kupffer cells
based on their expression of the macrophage-specific marker F4/80 (Fig.
2D). No TNF-
staining was seen in liver tissues from normal mice
(data not shown), and the TNF-
staining of Kupffer cells in
LPS-challenged mice was completely abolished by preabsorbing the
primary antibody with recombinant mouse TNF-
(Fig. 2E). These data
indicate that DEM decreased the serum TNF-
response to LPS, in large
part by inhibiting the synthesis of the cytokine in the liver.
Because Kupffer cells also expressed high densities of CD14 after LPS
challenge, this response was used to determine the specificity of DEM.
In contrast to Kupffer cell TNF-
expression, cellular CD14
expression was unaffected by DEM pretreatment (Fig. 2F versus G). This
result indicates that redox imbalance in the mouse liver differentially
inhibits LPS-induced macrophage gene expression rather than causing a
global inhibition of inflammatory responses.
Redox regulation of LPS-induced iNOS responses in the liver.
We then undertook a similar analysis of iNOS expression in the liver
based on the premise that TNF-
and iNOS expression represent two
independent signaling pathways in LPS-activated macrophages (2,
45, 63). Normal mouse livers contained few, if any, iNOS-expressing cells. When mice were either challenged with 100 µg
of LPS or pretreated with sesame oil and then challenged with LPS,
their livers contained numerous iNOS-positive cells 6 h later (Fig. 2H). These included Kupffer cells, hepatocytes, and sinusoidal endothelial cells, a finding that is consistent with those in previous
reports (1, 9, 13, 30, 50, 54). As reported by others
(36, 40), hepatocyte iNOS staining was not uniform throughout the liver and positive cells were often found adjacent to
blood vessels. Of interest, this pattern was similar to the distribution of staining obtained with antibody to LPS (data not shown). Pretreating mice with DEM had no effect on either the staining
intensity or the frequency of iNOS-positive Kupffer cells (Fig. 2I),
indicating that LPS-induced macrophage iNOS expression in the mouse
liver, like the CD14 response, was unaffected by redox stress. However,
iNOS expression by hepatocytes and endothelial cells was highly
sensitive to redox changes. DEM treatment essentially eliminated the
hepatocyte iNOS response to LPS and reduced the intensity of iNOS
expression by sinusoidal endothelial cells (Fig. 2H and I).
To estimate the magnitude of the effects of DEM on these in vivo liver
responses to LPS, the frequencies of TNF-
-, CD14-, and iNOS-positive
hepatic cells were determined. The results are summarized in Table
1 and demonstrate that TNF-
expression
by Kupffer cells was completely blocked in DEM-treated mice. By
contrast, both the Kupffer cell CD14 and iNOS responses were stress
resistant under these conditions. The frequency of hepatocytes
expressing iNOS was significantly decreased by DEM pretreatment as was
the intensity of iNOS staining by sinusoidal endothelial cells. These effects of DEM on iNOS expression in hepatocytes and endothelial cells
correlated with a significantly lower level of circulating nitrates and
nitrites in stressed animals measured 16 h after LPS challenge
(Fig. 4). Thus, glutathione depletion not
only decreased hepatocyte and hepatic endothelial cell iNOS responses
but also substantially impaired total nitric oxide synthesis in
response to LPS challenge.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Frequencies of various cell types in the livers of
DEM-treated, LPS-challenged C3HeB/FeJ mice that express TNF- , CD14,
or iNOS
|
|

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 4.
Serum nitrate and nitrite responses to LPS challenge are
inhibited by redox stress. (A) C3HeB/FeJ mice were treated with either
sesame oil or DEM and then challenged i.p. with 100 µg of S. enteritidis LPS. Sixteen hours later, serum nitrate and nitrite
concentrations were measured. Each point represents the response of a
single animal (six to seven mice per group), and the horizontal lines
indicate group means. Group results were significantly different from
one another (P < 0.01), as calculated by Student's
t test. The concentrations of nitrates and nitrites in the
sera of normal mice were less than 25 µM.
|
|
TNF-
-induced hepatic iNOS expression is redox regulated in
vivo.
Hepatocyte iNOS can be induced by TNF-
in vitro (1,
13, 30), and this response is inhibited by DEM (13).
Thus, the loss of the hepatocyte iNOS response in DEM-treated mice may
have resulted from either the decreased production of TNF-
or the direct effects of DEM on the hepatocytes themselves. To determine which
of these mechanisms explained the observations summarized in Table 1,
we challenged DEM-treated and control mice with recombinant mouse
TNF-
and measured hepatic iNOS expression. The results are shown in
Fig. 2K and L and summarized in Table 2.
While recombinant TNF-
was not an effective stimulus for inducing
iNOS in Kupffer cells or endothelial cells, it did stimulate strong
hepatocyte iNOS expression in control mice (Fig. 2K). However, this
response was absent in DEM-treated animals (Fig. 2L). Likewise,
exogenous TNF-
did not restore the hepatocyte iNOS response in
DEM-treated, LPS-challenged mice (data not shown). These findings
indicate that the hepatocyte iNOS response to TNF-
in vivo is
inherently stress sensitive and suggest that the loss of hepatocyte
iNOS expression in DEM-treated, LPS-challenged mice resulted from redox imbalance within the hepatocytes themselves.
 |
DISCUSSION |
A number of published reports indicate that redox stress can
substantially alter macrophage responses to LPS in vitro (6, 10,
14, 23, 25, 39, 41), but relatively few studies have determined
the significance of these findings with regard to intact, endotoxemic
animals (e.g., see reference 38). For this reason,
we treated mice with DEM to deplete cellular glutathione and
characterized the LPS-induced gene expression in the liver that
resulted. We included an analysis of TNF-
and iNOS expression because the results of several in vitro studies suggest that these responses represent two independent LPS signaling pathways in mouse
macrophages (2, 45, 63). Control, LPS-challenged mice
expressed high levels of hepatic TNF-
and iNOS protein, and elevated
levels of TNF-
and nitrate or nitrite were measured in their sera.
While Kupffer cell iNOS and CD14 expression were unaffected by DEM
treatment, TNF-
expression by these cells was virtually eliminated.
This pattern of gene expression differs somewhat from that reported by
Nathens et al. (38), who studied local responses to LPS in
the rat lung. In that study, DEM inhibited the expression of
intercellular adhesion molecule-1 by pulmonary endothelial cells
responding to the local instillation of LPS but did not affect TNF-
mRNA levels in lung tissues. The lack of an effect on TNF-
production in the lung may reflect differences between pulmonary and
hepatic macrophages and parallels the findings described by Matuschak
and colleagues (35, 59), who have compared TNF-
responses
in perfused rat livers and lungs elicited by challenge with viable
Escherichia coli bacteria. Transient hypoxia and
reoxygenation was found to inhibit TNF-
mRNA responses in the liver
but had the opposite effect in the lung. Thus, the same response can be regulated differently in these two organs, emphasizing the need to
evaluate each shock organ affected by endotoxemia independently. The
finding that two biochemically distinct forms of stress induction (i.e., DEM and BSO treatment) used in the present study produced similar effects on gene expression underscores the important conclusion that macrophage inflammatory genes inherently differ from one another
in their redox sensitivities in vivo.
A number of investigators (6, 8, 13, 24, 25, 28, 30, 41)
have shown that the expression of iNOS in cultured cells, including
macrophages, hepatocytes, and endothelial cells, is regulated by
cellular redox balance. For example, Buchmuller-Rouiller et al.
(6) reported that DEM treatment of mouse bone marrow-derived macrophages inhibited the induction of iNOS by LPS plus gamma interferon in vitro and both Hecker et al. (25) and Pahan et al. (41) showed that antioxidants blocked LPS-induced iNOS
expression in cultured murine macrophages. Glutathione depletion has
also been shown by a number of groups to substantially inhibit the expression of iNOS by primary cultures of hepatocytes (13,
25). By contrast, Kuo et al. (28) have more recently
reported that oxidant stress associated with superoxide formation
increased iNOS gene transcriptional activity in rat hepatocytes. For
this reason, we were interested in determining how redox stress
associated with glutathione depletion in vivo would affect iNOS
expression in the livers of endotoxin-challenged mice. The results of
this study indicate that there are substantial cell-type-specific
differences in this regard. While DEM treatment induced the expression
of HSP-32 in all three hepatic cell types studied, only the hepatocyte and endothelial cell iNOS responses to LPS challenge were inhibited by
redox stress. Kupffer cell iNOS expression was unaffected when glutathione was depleted in vivo with DEM. Thus, in addition to showing
gene-specific effects, oxidative stress in vivo shows cell type and,
perhaps, organ-specific effects, and one cannot always predict from in
vitro models the behavior of a given cell type in vivo.
Because hepatocytes contribute substantially to the systemic
inflammatory responses seen in endotoxemia (1, 7, 13, 26, 27,
32), it is important to understand how the activation of these
cells is regulated and what role Kupffer cells play in their responses
to LPS. Hepatocyte iNOS expression can be induced by TNF-
, a
response that depends on the type I TNF receptor (31). Although some differences of opinion exist regarding the role of
TNF-
as a required mediator of LPS-induced iNOS expression (51,
62), a recent study with type I TNF receptor-null mice indicates
that the expression of iNOS mRNA by at least some hepatic cells of
LPS-stimulated mice is highly TNF-
dependent (51). Thus,
the simplest explanation for decreased LPS-induced iNOS expression by
hepatocytes of DEM-treated mice was the absence of detectable TNF-
production by these animals. However, the finding that DEM inhibited
TNF-
-induced hepatocyte iNOS expression in vivo indicates that redox
changes in the hepatocytes themselves also regulate this response,
regardless of the availability of stimulating TNF-
. This
interpretation is consistent with the results of an earlier study by
Duval et al. (13), who showed that DEM can inhibit
TNF-
-induced rat hepatocyte iNOS expression in vitro.
An incidental finding reported in this study was the moderate
immunohistological staining of hepatic sinusoidal endothelial cells of
LPS-challenged mice with CD14 antibody (Fig. 2F), which was not seen in
the livers of unstimulated mice. We have not confirmed this reaction
with other CD14-specific antibodies, and at least three other reports
(16, 17, 33) have failed to note the expression of hepatic
endothelial cell CD14 protein or mRNA in LPS-challenged mice. Thus, the
significance of endothelial cell staining in the present study remains
to be determined.
Not surprisingly, inflammatory responses to gram-negative bacterial
infections also appear to be redox regulated. As noted above, Matushak
and his colleagues (34, 35, 59) have reported that E. coli-induced IL-1
and TNF-
gene expression in the perfused rat liver and lung can be regulated by brief hypoxia followed by
reoxygenation, a treatment that is thought to induce radical formation.
A greater understanding of the specific redox-regulated changes that
occur during gram-negative infections, compared to those seen in
endotoxemia, would aid in predicting the outcomes of therapies directed
at restoring redox balance. The results of the present study suggest
that such therapies would indeed enhance the expression of certain
proinflammatory genes in the liver (e.g., the TNF-
gene) and may
have other unexpected effects.
 |
ACKNOWLEDGMENTS |
This work was supported by grant KS-97-GS-62 from the American
Heart Association. F.W. was a recipient of a fellowship from the
Infectious Disease and Cancer Training Program of the Kansas Health
Foundation/Margaret Jane Harley Fund.
We thank David Morrison for his contributions to this study. Joan Hunt
generously provided the antibody F4/80. We also thank Glen Andrews for
his advice and comments about the manuscript.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology, Molecular Genetics and Immunology, University of Kansas Medical Center, 3901 Rainbow Blvd., Kansas City, KS 66160-7420. Phone:
(913) 588-7053. Fax: (913) 588-7295. E-mail:
mparmely{at}kumc.edu.
Editor:
J. T. Barbieri
 |
REFERENCES |
| 1.
|
Adamson, G. M., and R. E. Billings.
1993.
Cytokine toxicity and induction of NO synthase activity in cultured mouse hepatocytes.
Toxicol. Appl. Pharmacol.
119:100-107[Medline].
|
| 2.
|
Amura, C. R.,
L. C. Chen,
N. Hirohashi,
M. G. Lei, and D. C. Morrison.
1997.
Two functionally independent pathways for lipopolysaccharide-dependent activation of mouse peritoneal macrophages.
J. Immunol.
159:5079-5083[Abstract].
|
| 3.
|
Austin, J. M., and S. Gordon.
1981.
F4/80, a monoclonal antibody directed specifically against the mouse macrophage.
Eur. J. Immunol.
11:805-815[Medline].
|
| 4.
|
Bautista, A. P.,
K. Meszaros,
J. Bojta, and J. J. Spitzer.
1990.
Superoxide anion generation in the liver during the early stages of endotoxemia in rats.
J. Leukoc. Biol.
48:123-128[Abstract].
|
| 5.
|
Bradford, M.
1976.
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
Anal. Biochem.
72:248-254[Medline].
|
| 6.
|
Buchmuller-Rouiller, Y.,
S. B. Corradin,
J. Smith,
P. Schneider,
A. Ransijn,
C. V. Jongeneel, and J. Mauel.
1995.
Role of glutathione in macrophage activation: effect of cellular glutathione depletion on nitrite production and leishmanicidal activity.
Cell. Immunol.
164:73-80[Medline].
|
| 7.
|
Chensue, S. W.,
P. D. Terebuh,
D. G. Remick,
W. E. Scales, and S. L. Kunkel.
1991.
In vivo biologic and immunohistochemical analysis of interleukin-1 alpha, beta and tumor necrosis factor during experimental endotoxemia. Kinetics, Kupffer cell expression, and glucocorticoid effects.
Am. J. Pathol.
138:395-402[Abstract].
|
| 8.
|
Colasanti, M.,
T. Persichini,
M. Menegazzi,
S. Mariotto,
E. Giordano,
C. M. Caldarera,
V. Sogos,
G. M. Laura, and H. Suzuki.
1995.
Induction of nitric oxide synthase mRNA expression. Suppression by exogenous nitric oxide.
J. Biol. Chem.
270:26731-26733[Abstract/Free Full Text].
|
| 9.
|
Curran, R. D.,
T. R. Billiar,
D. J. Stuehr,
K. Hofmann, and R. L. Simmons.
1989.
Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells.
J. Exp. Med.
170:1769-1774[Abstract/Free Full Text].
|
| 10.
|
DeForge, L. E.,
A. M. Preston,
E. Takeuchi,
J. Kenney,
L. A. Boxer, and D. G. Remmick.
1993.
Regulation of interleukin 8 gene expression by oxidant stress.
J. Biol. Chem.
268:25568-25576[Abstract/Free Full Text].
|
| 11.
|
Deneke, S. M., and B. L. Fanburg.
1989.
Regulation of cellular glutathione.
Am. J. Physiol.
257:L163-L173[Abstract/Free Full Text].
|
| 12.
|
Dhaunsi, G. S.,
I. Singh, and C. D. Hanevold.
1993.
Peroxisomal participation in the cellular responses to the oxidative stress of endotoxin.
Mol. Cell. Biochem.
126:25-35[Medline].
|
| 13.
|
Duval, D. L.,
D. J. Sieg, and R. E. Billings.
1995.
Regulation of hepatic nitric oxide synthase by reactive oxygen intermediates and glutathione.
Arch. Biochem. Biophys.
316:699-706[Medline].
|
| 14.
|
Eigler, A.,
J. Moeller, and S. Endres.
1995.
Exogenous and endogenous nitric oxide attenuates tumor necrosis factor synthesis in the murine macrophage cell line RAW 264.7.
J. Immunol.
154:4048-4054[Abstract].
|
| 15.
|
Ewing, J. F., and M. D. Maines.
1993.
Glutathione depletion induces heme oxygenase-1 (HSP32) mRNA and protein in rat brain.
J. Neurochem.
60:1512-1519[Medline].
|
| 16.
|
Fearns, C.,
V. V. Kravchenko,
R. J. Ulevitch, and D. J. Loskutoff.
1995.
Murine CD14 gene expression in vivo: extramyeloid synthesis and regulation by lipopolysaccharide.
J. Exp. Med.
181:857-866[Abstract/Free Full Text].
|
| 17.
|
Fearns, C., and D. J. Loskutoff.
1997.
Role of tumor necrosis factor alpha in induction of murine CD14 gene expression by lipopolysaccharide.
Infect. Immun.
65:4822-4831[Abstract].
|
| 18.
|
Felix, R.,
M. G. Cecchini,
W. Hofstetter,
P. R. Elford,
A. Stuttzer, and H. Fleisch.
1990.
Impairment of macrophage colony-stimulating factor production and lack of resident bone marrow macrophages in the osteopetrotic op/op mouse.
J. Bone Miner. Res.
5:781-789[Medline].
|
| 19.
|
Feng, L.,
Y. Xia,
G. E. Garcia,
D. Hwang, and C. G. Wilson.
1995.
Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor- , and lipopolysaccharide.
J. Clin. Investig.
95:1669-1675.
|
| 20.
|
Fu, K.,
M. P. Sarras,
R. C. De Lisle, and G. K. Andrews.
1997.
Expression of oxidative stress-responsive genes and cytokine genes during caerulein-induced acute pancreatitis.
Am. J. Physiol.
273:G696-G705[Abstract/Free Full Text].
|
| 21.
|
Ghosh, B.,
C. D. Hanevold,
K. Dobashi,
J. K. Ovak, and I. Singh.
1996.
Tissue differences in antioxidant enzyme gene expression in response to endotoxin.
Free Radic. Biol. Med.
21:533-540[Medline].
|
| 22.
|
Griffith, O. W., and A. Meister.
1979.
Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine).
J. Biol. Chem.
254:7558-7560[Abstract/Free Full Text].
|
| 23.
|
Griscavage, J. M.,
N. E. Rogers,
M. P. Sherman, and L. J. Ignarro.
1993.
Inducible nitric oxide synthase from a rat alveolar macrophage cell line is inhibited by nitric oxide.
J. Immunol.
151:6329-6337[Abstract].
|
| 24.
|
Harbecht, B. G.,
M. Di Silvio,
V. Chough,
Y.-M. Kim,
R. L. Simmons, and T. R. Billiar.
1997.
Glutathione regulates nitric oxide synthase in cultured hepatocytes.
Ann. Surg.
225:76-87[Medline].
|
| 25.
|
Hecker, M.,
C. Preiss,
P. Klemm, and R. Busse.
1996.
Inhibition by antioxidants of nitric oxide synthase expression in murine macrophages: role of nuclear factor B and interferon regulatory factor 1.
Brit. J. Pharmacol.
118:2178-2184[Medline].
|
| 26.
|
Koj, A.
1989.
The role of interleukin-6 as the hepatocyte stimulating factor in the network of inflammatory cytokines.
Ann. N. Y. Acad. Sci.
557:1-8.
|
| 27.
|
Kumins, N. H.,
J. Hunt,
R. L. Gamelli, and J. P. Filkins.
1996.
Partial hepatectomy reduces the endotoxin-induced peak circulating level of tumor necrosis factor in rats.
Shock
5:385-388[Medline].
|
| 28.
|
Kuo, P. C.,
K. Y. Abe, and R. A. Schroeder.
1997.
Oxidative stress increases hepatocyte iNOS gene transcription and promoter activity.
Biochem. Biophys. Res. Commun.
234:289-292[Medline].
|
| 29.
|
Landmann, R.,
F. Scherer,
R. Schumann,
S. Link,
S. Sansano, and W. Zimmerli.
1995.
LPS directly induces oxygen radical production in human monocytes via LPS binding protein and CD14.
J. Leukoc. Biol.
57:440-449[Abstract].
|
| 30.
|
Laskin, D. L.,
D. E. Heck,
C. R. Gardner,
L. S. Feder, and J. L. Laskin.
1994.
Distinct patterns of nitric oxide production in hepatic macrophages and endothelial cells following acute exposure of rats to endotoxin.
J. Leukoc. Biol.
56:751-758[Abstract].
|
| 31.
|
Leist, M.,
F. Gantner,
S. Jilg, and A. Wendel.
1995.
Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release.
J. Immunol.
154:1307-1316[Abstract].
|
| 32.
|
Luster, M. I.,
D. R. Germolec,
T. Yoshida,
F. Kayama, and M. Thompson.
1994.
Endotoxin-induced cytokine gene expression and excretion in the liver.
Hepatology
19:480-488[Medline].
|
| 33.
|
Matsuura, K.,
T. Ishida,
M. Setoguchi,
Y. Higuchi,
S. Akizuki, and S. Yamamoto.
1994.
Upregulation of mouse CD14 expression in Kupffer cells by lipopolysaccharide.
J. Exp. Med.
179:1671-1676[Abstract/Free Full Text].
|
| 34.
|
Matuschak, G. M.,
C. A. Johanns,
Z. Chen,
J. Gaynor, and A. J. Lechner.
1996.
Brief hypoxic stress downregulates E. coli-induced IL-1 and IL-1 gene expression in perfused liver.
Am. J. Physiol.
271:R1311-R1318[Abstract/Free Full Text].
|
| 35.
|
Matuschak, G. M.,
C. F. Munoz,
C. A. Johanns,
R. Rahman, and A. J. Lechner.
1998.
Upregulation of postbacteremic TNF- and IL-1 gene expression by alveolar hypoxia/reoxygenation in perfused rat lungs.
Am. J. Respir. Crit. Care Med.
157:629-637[Abstract/Free Full Text].
|
| 36.
|
Morikawa, A.,
Y. Kato,
T. Sugiyama,
N. Koide,
D. Chakravortty,
T. Yoshida, and T. Yokochi.
1999.
Role of nitric oxide in lipopolysaccharide-induced hepatic injury in D-galactosamine-sensitized mice as an experimental endotoxic shock model.
Infect. Immun.
67:1018-1024[Abstract/Free Full Text].
|
| 37.
|
Munoz, C.,
M. C. Castellanos,
A. Alfranca,
A. Vara,
M. A. Esteban,
J. M. Redondo, and M. O. de Landazuri.
1996.
Transcriptional up-regulation of intracellular adhesion molecule-1 on human endothelial cells by the antioxidant pyrrolidine dithiocarbamate involves the activation of activating protein-1.
J. Immunol.
157:3587-3597[Abstract].
|
| 38.
|
Nathens, A. B.,
R. Biaar,
R. W. G. Watson,
T. B. Issekutz,
J. C. Marshall,
A. P. B. Dackiw, and O. D. Rotstein.
1998.
Thiol-mediated regulation of ICAM-1 expression in endotoxin-induced acute lung injury.
J. Immunol.
160:2959-2966[Abstract/Free Full Text].
|
| 39.
|
Neuschwander-Tetri, B. A.,
J. M. Bellezzo,
B. S. Britton,
B. R. Bacon, and E. S. Fox.
1996.
Thiol regulation of endotoxin-induced release of tumor necrosis factor from isolated rat Kupffer cells.
Biochem. J.
320:1005-1010.
|
| 40.
|
Osei, S. Y.,
R. S. Ahima,
M. E. Fabry,
R. L. Nagel, and N. Bank.
1996.
Immunohistological localization of hepatic nitric oxide synthase in normal and transgenic sickle cell mice: the effects of hypoxia.
Blood
88:3583-3588[Abstract/Free Full Text].
|
| 41.
|
Pahan, K.,
F. G. Sheikh,
A. M. S. Namboodiri, and I. Singh.
1998.
N-Acetyl cysteine inhibits induction of NO production by endotoxin or cytokine stimulated rat peritoneal macrophages, C6 glial cells and astrocytes.
Free Radic. Biol. Med.
24:39-48[Medline].
|
| 42.
|
Park, K. K.,
H. L. Lin, and S. Murphy.
1997.
Nitric oxide regulates nitric oxide synthase-2 gene expression by inhibiting NF- B binding to DNA.
Biochem. J.
322:609-613.
|
| 43.
|
Parmely, M. J.
1999.
Nitric oxide as a signaling molecule in the systemic inflammatory response to LPS, p. 591-604.
In
H. Brade, D. Morrison, S. Opal, and S. Vogel (ed.), Endotoxin in health and disease. Marcel Dekker, New York, N.Y.
|
| 44.
|
Parmely, M. J.,
A. Gale,
M. Clabaugh,
R. Horvat, and W.-W. Zhou.
1990.
Proteolytic inactivation of cytokines by Pseudomonas aeruginosa.
Infect. Immun.
58:3009-3014[Abstract/Free Full Text].
|
| 45.
|
Parmely, M. J.,
S.-Y. Hao,
D. C. Morrison, and J. L. Pace.
1995.
Role of macrophage-derived nitric oxide in endotoxin lethality in mice.
J. Endotoxin Res.
2:45-52.
|
| 46.
|
Peavy, D. L., and E. J. Fairchild, II.
1986.
Evidence for lipid peroxidation in endotoxin-poisoned mice.
Infect. Immun.
52:613-616[Abstract/Free Full Text].
|
| 47.
|
Peng, H.-B.,
T. B. Rajavashisth,
P. Libby, and J. K. Liao.
1995.
Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells.
J. Biol. Chem.
270:17050-17055[Abstract/Free Full Text].
|
| 48.
|
Portoles, M. T.,
M. Tatala,
A. Anton, and R. Pagani.
1996.
Hepatic response to the oxidative stress induced by E. coli endotoxin: glutathione as an index of the acute phase during the endotoxic shock.
Mol. Cell. Biochem.
159:115-121[Medline].
|
| 49.
|
Rizzardini, M.,
M. Carelli,
M. R. Cabello Porras, and L. Cantoni.
1994.
Mechanisms of endotoxin-induced haem oxygenase mRNA accumulation in mouse liver: synergism by glutathione depletion and protection by N-acetylcysteine.
Biochem. J.
304:477-483.
|
| 50.
|
Rockey, D. C., and J. J. Chung.
1996.
Regulation of inducible nitric oxide synthase in hepatic sinusoidal endothelial cells.
Am. J. Physiol.
271:G260-G267[Abstract/Free Full Text].
|
| 51.
|
Salkowski, C. A.,
G. Detore,
R. McNally,
N. van Rooijen, and S. N. Vogel.
1997.
Regulation of inducible nitric oxide synthase messenger RNA expression and nitric oxide production by lipopolysaccharide in vivo.
J. Immunol.
158:905-912[Abstract].
|
| 52.
|
Scheffler, L. A.,
D. A. Wink,
G. Melillo, and G. W. Cox.
1995.
Exogenous nitric oxide regulates IFN- plus lipopolysaccharide-induced nitric oxide synthase expression in mouse macrophages.
J. Immunol.
155:886-894[Abstract].
|
| 53.
|
Schmidt, H. H. H. W.,
T. D. Warner,
M. Nakane,
U. Forstermann, and F. Murad.
1992.
Regulation and subcellular location of nitrogen oxide synthase in RAW 264.7 macrophages.
Mol. Pharmacol.
41:615-624[Abstract].
|
| 54.
|
Spitzer, J. A.
1994.
Cytokine stimulation of nitric oxide formation and differential regulation in hepatocytes and nonparenchymal cells of endotoxemic rats.
Hepatology
19:217-228[Medline].
|
| 55.
|
Spolarics, Z.
1996.
Endotoxin stimulates gene expression of ROS-eliminating pathways in rat hepatic endothelial and Kupffer cells.
Am. J. Physiol.
270:G660-G666[Abstract/Free Full Text].
|
| 56.
|
Sugino, K.,
K. Dohi,
K. Yamada, and T. Kawasaki.
1989.
Changes in the levels of endogenous antioxidants in the liver of mice with experimental endotoxemia and the protective effects of the antioxidants.
Surgery
105:200-206[Medline].
|
| 57.
|
Tietze, F.
1969.
Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues.
Anal. Biochem.
27:502-522[Medline].
|
| 58.
|
Uhlig, S., and A. Wendel.
1992.
The physiological consequences of glutathione variations.
Life Sci.
51:1083-1094[Medline].
|
| 59.
|
Wibbenmeyer, L. A.,
A. J. Lechner,
C. F. Munoz, and G. M. Matuschak.
1995.
Downregulation of E. coli-induced TNF- expression in perfused liver by hypoxia-reoxygenation.
Am. J. Physiol.
268:G311-G319[Abstract/Free Full Text].
|
| 60.
|
Wizemann, T. M.,
C. R. Gardner,
J. D. Laskin,
S. Quinones,
S. K. Durham,
N. L. Goller,
S. T. Ohnishi, and D. L. Laskin.
1994.
Production of nitric oxide and peroxynitrite in the lung during acute endotoxemia.
J. Leukoc. Biol.
56:759-768[Abstract].
|
| 61.
|
Wong, C.,
J. Flynn, and R. H. Demling.
1984.
Role of oxygen radicals in endotoxin-induced lung injury.
Arch. Surg.
119:77-82[Abstract].
|
| 62.
|
Xie, J.,
K. O. Joseph,
G. J. Bagby,
T. D. Giles, and S. S. Greenberg.
1997.
Dissociation of TNF- from endotoxin-induced nitric oxide and acute-phase hypotension.
Am. J. Physiol.
273:H164-H174[Abstract/Free Full Text].
|
| 63.
|
Zhang, X., and D. C. Morrison.
1993.
Lipopolysaccharide-induced selective priming effects on TNF- and nitric oxide production.
J. Exp. Med.
177:511-516[Abstract/Free Full Text].
|
Infection and Immunity, October 1999, p. 5409-5416, Vol. 67, No. 10
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Bokhari, S. M., Kim, K.-J., Pinson, D. M., Slusser, J., Yeh, H.-W., Parmely, M. J.
(2008). NK Cells and Gamma Interferon Coordinate the Formation and Function of Hepatic Granulomas in Mice Infected with the Francisella tularensis Live Vaccine Strain. Infect. Immun.
76: 1379-1389
[Abstract]
[Full Text]
-
Song, M., Kellum, J. A., Kaldas, H., Fink, M. P.
(2004). Evidence That Glutathione Depletion Is a Mechanism Responsible for the Anti-Inflammatory Effects of Ethyl Pyruvate in Cultured Lipopolysaccharide-Stimulated RAW 264.7 Cells. J. Pharmacol. Exp. Ther.
308: 307-316
[Abstract]
[Full Text]
-
Zhang, G., Nichols, R. D., Taniguchi, M., Nakayama, T., Parmely, M. J.
(2003). Gamma Interferon Production by Hepatic NK T Cells during Escherichia coli Infection Is Resistant to the Inhibitory Effects of Oxidative Stress. Infect. Immun.
71: 2468-2477
[Abstract]
[Full Text]
-
Parmely, M. J., Wang, F., Wright, D.
(2001). Gamma Interferon Prevents the Inhibitory Effects of Oxidative Stress on Host Responses to Escherichia coli Infection. Infect. Immun.
69: 2621-2629
[Abstract]
[Full Text]